Isolation and molecular characterization of a novel type 3 reovirus from a child with meningitis

Journal of Infectious Diseases

Volumn 189, Issue 9, 2004, Pages 1664-1675

  Tyler, Kenneth L ^a,b   Barton, Erik S ^c,d   Ibach, Maria L ^a   Robinson, Christine ^a   Campbell, Jacquelyn A ^c   O'Donnell, Sean M ^c   Valyi Nagy, Tibor ^c,e   Clerke, Penny ^a   Wetzel, J Denise ^c   Dermody, Terence S ^c  

^a CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ENCEPHALITIS; FEMALE; GENETIC CODE; HEMAGGLUTINATION; HUMAN; HUMAN CELL; INFANT; INOCULATION; LABORATORY TEST; MENINGITIS; MOUSE; NEUROLOGIC EXAMINATION; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REOVIRUS; SEQUENCE ANALYSIS; SERODIAGNOSIS; SEROTYPE; VIRUS CHARACTERIZATION; VIRUS GENE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; ANIMALS, NEWBORN; CAPSID PROTEINS; CELL LINE; CEREBROSPINAL FLUID; FEMALE; HELA CELLS; HUMANS; INFANT; MAMMALIAN ORTHOREOVIRUS 3; MENINGITIS, VIRAL; MICE; MOLECULAR SEQUENCE DATA; REOVIRIDAE INFECTIONS; SEQUENCE ANALYSIS, DNA; SEROTYPING;

EID: 2442545193     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/383129     Document Type: Article

References (70)

1. Nibert ML, Schiff LA. Reoviruses and their replication. In: Knipe DM, Howley PM, eds. Fields virology. 4th ed. Philadelphia: Lippincott-Raven, 2001:1679-728.
2. Sabin AB. Reoviruses: a new group of respiratory and enteric viruses formerly classified as ECHO type 10 is described. Science 1959; 130: 1387-9.
3. Rosen L. Serologic grouping of reovirus by hemagglutination-inhibition. Am J Hyg 1960; 71:242-9.
4. Tyler KL. Mammalian reoviruses. In: Knipe DM, Howley PM, eds. Fields virology. 4th ed. Philadelphia: Lippincott-Raven, 2001:1729-945.
5. Jackson GG, Muldoon RL, Cooper RS. Reovirus type 1 as an etiologic agent of the common cold. J Clin Invest 1961; 40:1051.
6. Lerner AM, Cherry JD, Klein JO, Finland M. Infections with reoviruses. N Engl J Med 1962; 267:947-52.
7. Leers WD, Rozee KR. A survey of reovirus antibodies in sera of urban children. Can Med Assoc J 1966; 94:1040-2.
8. Tyler KL. Pathogenesis of reovirus infections of the central nervous system. Curr Top Microbiol Immunol 1998; 233:93-124.
9. Krainer L, Aronson BE. Disseminated encephalomyelitis in humans with recovery of hepatoencephalitis virus. J Neuropathol Exp Neurol 1959; 18:339-42.
10. Joske RA, Keall DD, Leak PJ, Stanley NF, Walters MN. Hepatitis- encephalitis in humans with reovirus infections. Arch Intern Med 1964; 113:811-6.
11. Johansson PJ, Sveger T, Ahlfors K, Ekstrand J, Svensson L. Reovirus type 1 associated with meningitis. Scand J Infect Dis 1996; 28:117-20.
12. Wolf JL, Rubin DH, Finberg R, et al. Intestinal M cells: a pathway of entry of reovirus into the host. Science 1981; 212:471-2.
13. Tyler KL, McPhee DA, Fields BN. Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science 1986; 233: 770-4.
14. Weiner HL, Powers ML, Fields BN. Absolute linkage of virulence and central nervous system tropism of reoviruses to viral hemagglutinin. J Infect Dis 1980; 141:609-16.
15. Weiner HL, Drayna D, Averill DR Jr, Fields BN. Molecular basis of reovirus virulence: role of the S1 gene. Proc Natl Acad Sci USA 1977; 74: 5744-8.
16. Morrison LA, Sidman RL, Fields BN. Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers. Proc Natl Acad Sci USA 1991; 88:3852-6.
17. Tardieu M, Powers ML, Weiner HL. Age-dependent susceptibility to reovirus type 3 encephalitis: role of viral and host factors. Ann Neurol 1983; 13:602-7.
18. Dichter MA, Weiner HL. Infection of neuronal cell cultures with reovirus mimics in vitro patterns of neurotropism. Ann Neurol 1984; 16:603-10.
19. Weiner HL, Ault KA, Fields BN. Interaction of reovirus with cell surface receptors. I. Murine and human lymphocytes have a receptor for the hemagglutinin of reovirus type 3. J Immunol 1980; 124:2143-8.
20. Lee PW, Hayes EC, Joklik WK. Protein σ1 is the reovirus cell attachment protein. Virology 1981; 108:156-63.
21. Furlong DB, Nibert ML, Fields BN. Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J Virol 1988; 62:246-56.
22. Banerjea AC, Brechling KA, Ray CA, Erikson H, Pickup DJ, Joklik WK. High-level synthesis of biologically active reovirus protein σ1 in a mammalian expression vector system. Virology 1988; 167:601-12.
23. Fraser RDB, Furlong DB, Trus BL, Nibert ML, Fields BN, Steven AC. Molecular structure of the cell-attachment protein of reovirus: correlation of computer-processed electron micrographs with sequence-based predictions. J Virol 1990; 64:2990-3000.
24. Chappell JD, Gunn VL, Wetzel JD, Baer GS, Dermody TS. Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein σ1. J Virol 1997; 71:1834-41.
25. Chappell JD, Duong JL, Wright BW, Dermody TS. Identification of carbohydrate-binding domains in the attachment proteins of type 1 and type 3 reoviruses. J Virol 2000; 74:8472-9.
26. Barton ES, Forrest JC, Connolly JL, et al. Junction adhesion molecule is a receptor for reovirus. Cell 2001; 104:441-51.
27. Nibert ML, Chappell JD, Dermody TS. Infectious subvirion particles of reovirus type 3 Dearing exhibit a loss in infectivity and contain a cleaved σ1 protein. J Virol 1995; 69:5057-67.
28. Chappell JD, Barton ES, Smith TH, et al. Cleavage susceptibility of reovirus attachment protein σ1 during proteolytic disassembly of virions is determined by a sequence polymorphism in the σ1 neck. J Virol 1998; 72:8205-13.
29. Bodkin DK, Fields BN. Growth and survival of reovirus in intestinal tissue: role of the L2 and S1 genes. J Virol 1989; 63:1188-93.
30. Tyler KL, Squier MK, Rodgers SE, et al. Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein σ1. J Virol 1995; 69:6972-9.
31. Rodgers SE, Barton ES, Oberhaus SM, et al. Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2. J Virol 1997; 71:2540-6.
32. Connolly JL, Rodgers SE, Clarke P, et al. Reovirus-induced apoptosis requires activation of transcription factor NF-κB. J Virol 2000; 74: 2981-9.
33. Clarke P, Meintzer SM, Gibson S, et al. Reovirus-induced apoptosis is mediated by TRAIL. J Virol 2000; 74:8135-9.
34. Richardson-Burns SM, Kominsky DJ, Tyler KL. Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors. J Neurovirol 2002; 8:365-80.
35. Oberhaus SM, Smith RL, Clayton GH, Dermody TS, Tyler KL. Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J Virol 1997; 71:2100-6.
36. DeBiasi R, Edelstein C, Sherry B, Tyler K. Calpain inhibition protects against virus-induced apoptotic myocardial injury. J Virol 2001; 75: 351-61.
37. Connolly JL, Barton ES, Dermody TS. Reovirus binding to cell surface sialic acid potentiates virus-induced apoptosis. J Virol 2001; 75:4029-39.
38. Virgin HW 4th, Bassel-Duby R, Fields BN, Tyler KL. Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J Virol 1988; 62:4594-604.
39. Smith RE, Zweerink HJ, Joklik WK. Polypeptide components of virions, top component and cores of reovirus type 3. Virology 1969; 39: 791-810.
40. Virgin HW 4th, Mann MA, Fields BN, Tyler KL. Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action. J Virol 1991; 65:6772-81.
41. Burstin SJ, Spriggs DR, Fields BN. Evidence for functional domains on the reovirus type 3 hemagglutinin. Virology 1982; 117:146-55.
42. Liu Y, Nusrat A, Schnell FJ, et al. Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci 2000; 113: 2363-74.
43. Wilson GJ, Wetzel JD, Puryear W, Bassel-Duby R, Dermody TS. Persistent reovirus infections of L cells select mutations in viral attachment protein σ1 that alter oligomer stability. J Virol 1996; 70:6598-606.
44. Dermody TS, Nibert ML, Bassel-Duby R, Fields BN. Sequence diversity in S1 genes and S1 translation products of 11 serotype 3 reovirus strains. J Virol 1990; 64:4842-50.
45. Hsu KH, Lonberg-Holm K, Alstein B, Crowell RL. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J Virol 1988; 62:1647-52.
46. Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275:1320-3.
47. Wetzel JD, Chappell JD, Fogo AB, Dermody TS. Efficiency of viral entry determines the capacity of murine erythroleukemia cells to support persistent infections by mammalian reoviruses. J Virol 1997; 71: 299-306.
48. Tyler KL, Bronson RT, Byers KB, Fields BN. Molecular basis of viral neurotropism: experimental reovirus infection. Neurology 1985; 35:88-92.
49. Rubin DH, Fields BN. Molecular basis of reovirus virulence: role of the M2 gene. J Exp Med 1980; 152:853-68.
50. Reed LJ, Muench H. A simple method of estimating fifty percent end-points. Am J Hyg 1938; 27:493-97.
51. Lerner AM, Cherry JD, Finland M. Haemagglutination with reoviruses. Virology 1963; 19:58-65.
52. Dermody TS, Nibert ML, Bassel-Duby R, Fields BN. A σ1 region important for hemagglutination by serotype 3 reovirus strains. J Virol 1990; 64:5173-6.
53. Felsenstein J. PHYLIP 3.2 manual. Berkeley: University of California Herbarium, 1989.
54. Rubin DH, Weiner DB, Dworkin C, Greene MI, Maul GG, Williams WV. Receptor utilization by reovirus type 3: distinct binding sites on thymoma and fibroblast cell lines result in differential compartmentalization of virions. Microb Pathog 1992; 12:351-65.
55. Kaye KM, Spriggs DR, Bassel-Duby R, Fields BN, Tyler KL. Genetic basis for altered pathogenesis of an immune-selected antigenic variant of reovirus type 3 Dearing. J Virol 1986; 59:90-7.
56. Bassel-Duby R, Spriggs DR, Tyler KL, Fields BN. Identification of attenuating mutations on the reovirus type 3 S1 double-stranded RNA segment with a rapid sequencing technique. J Virol 1986; 60:64-7.
57. Tyler KL, Virgin HW, Bassel-Duby R, Fields BN. Antibody inhibits defined stages in the pathogenesis of reovirus serotype 3 infection of the central nervous system. J Exp Med 1989; 170:887-900.
58. Tyler KL, Mann MA, Fields BN, Virgin HW 4th. Protective anti-reovirus antibodies and their effects on viral pathogenesis. J Virol 1993; 67: 3446-53.
59. Barton ES, Youree BE, Ebert DH, et al. Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease. J Clin Invest 2003; 111:1823-33.
60. Mann MA, Knipe DM, Fischbach GD, Fields BN. Type 3 reovirus neuroinvasion after intramuscular inoculation: direct invasion of nerve terminals and age-dependent pathogenesis. Virology 2002; 303:222-31.
61. Cuff CF, Lavi E, Cebra CK, Rubin DH. Passive immunity to fetal reovirus serotype 3-induced meningoencephalitis mediated by both secretory and transplacental factors in neonatal mice. J Virol 1990; 64:1256-63.
62. Kapikian A, Hoshino Y, Chanock R. Rotaviruses. In: Knipe DM, Howley PM, eds. Fields virology. 4th ed. Philadelphia: Lippincott-Raven, 2001:1787-833.
63. Lynch M, Lee B, Azimi P, et al. Rotavirus and central nervous system symptoms: cause or contaminant? Case reports and review. Clin Infect Dis 2001; 33:932-8.
64. Wong CJ, Price Z, Bruckner DA. Aseptic meningitis in an infant with rotavirus gastroenteritis. Pediatr Infect Dis 1984; 3:244-6.
65. Klasco R. Colorado tick fever. Med Clin North Am 2002; 86:435-40, ix.
66. Ramos-Alvarez M, Sabin AB. Characteristics of poliomyelitis and other enteric viruses recovered in tissue culture from healthy American children. Proc Soc Exp Biol Med 1954; 87:655-61.
67. Ramos-Alvarez M, Sabin AB. Enteropathogenic viruses and bacteria: role in summer diarrheal diseases of infancy and early childhood. JAMA 1958; 167:147-58.
68. Hrdy DB, Rosen L, Fields BN. Polymorphism of the migration of double-stranded RNA segments of reovirus isolates from humans, cattle, and mice. J Virol 1979; 31:104-11.
69. Rosen L, Hovis JF, Mastrota FM, Bell JA, Huebner RJ. Observations on a newly recognized virus (Abney) of the reovirus family. Am J Hyg 1960; 71:258-65.
70. Goral MI, Mochow-Grundy M, Dermody TS. Sequence diversity within the reovirus S3 gene: reoviruses evolve independently of host species, geographic locale, and date of isolation. Virology 1996; 216:265-71.